The US Centers for Disease Control and Prevention (CDC) has caused a stir after recommending the use of the Johnson & Johnson Johnson vaccine for blood clots following reports that six women suffered from a rare and severe type of blood clot after vaccination. The news sparked a debate about blood clots, which revolve around birth control and the potential for a vaccine against the disease.

On April 13, the CDC and FDA issued a joint statement recommending that healthcare providers temporarily halt the administration of the Johnson & Johnson vaccine and jointly announced that an investigation into possible safety concerns has been approved by the FDA and CDC.

In the 6.8 million doses of the vaccine administered in the US so far, six people have suffered rare blood clots in their brains, a condition in which blood effectively clots. It is worth noting that the nationwide administration of this highly effective vaccine has been halted until the authorities can conduct an investigation. This is not to minimize the severity of the deaths caused by vaccination.

Some medical experts fear that a longer pause in vaccinations could increase vaccine delay and cause more problems in the future.

Federal authorities could take two weeks or more to learn whether Johnson & Johnson’s coronavirus vaccine is linked to rare blood clots, Politico reported Saturday. According to a Washington Post report, US regulators recommend that women who have recently received the vaccine be revaccinated.

The most common type of blood clot studied on Johnson & Johnson vaccine recipients is cerebral venous sinus thrombosis (CVST), which means it occurs in a vein that drains blood from the brain. It can lead to headaches and strokes, but also heart attacks, strokes and even death.

The CDC and FDA recommend that people treated with the Johnson & Johnson vaccine who show mild symptoms of blood clots in their veins within three weeks of vaccination, such as headaches, dizziness, nausea, vomiting and diarrhea. Minor symptoms are not a cause for concern, but they are common in those who receive the vaccine.

WBZ – Television’s Dr. Mallika Marshall reveals what you need to know when you get the vaccine. The CDC and FDA have called for a pause in the Johnson & Johnson coronavirus vaccine after a patient contracted a rare blood clot. Please make sure you talk to your doctor about any concerns about using this vaccine, as well as any possible side effects such as blood clots, the CDC said.

As always, you should consult your personal physician before making any decision about your personal health, and Dr. Mallika offers some of her best advice.

To learn more about the first cases of TTS identified by experts and why the CDC and FDA recommend a pause, please read the original report below.

Johnson & Johnson’s COVID-19 vaccine remains in limbo after government health advisers said Wednesday that they need more evidence to determine whether a handful of unusual blood clots are linked to the shot and how big the risk really is. Health officials have called for a temporary pause while the two agencies investigate a possible link, but it is not yet clear whether the vaccine is really the cause of the problem. Today, the US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended that Johnson and Johnson’s COID-19 vaccine be suspended in the United States because it could increase the risk of a rare type of blood clot.

The report is part of an ongoing investigation by the CDC and FDA into the possible link between the vaccine and a handful of unusual blood clots.

At an emergency meeting, advisers to the Centers for Disease Control and Prevention wrestled with whether the US has enough alternatives to the vaccine for its vaccinated population, and whether other countries are anxiously waiting – and – ready. European regulators said such clots were rare and a potential risk because the vaccines were manufactured in a similar way and not yet approved in the United States, and the government recommended a pause in J & J vaccinations. One doctor said the Johnson & Johnson vaccination pause should not deter people from getting vaccinated, but may not.

But Dr Sampson-Davis pointed out that so much had been achieved in overcoming this situation, he said, pointing to a number of factors, including the safety of the vaccine.

Dr. Anne Schuchat spoke exclusively to Good Morning America about the issue, and the FDA and CDC have recommended that six women develop rare blood clots linked to the Johnson & Johnson vaccine. All six women who developed a blood clot link to Johnson and Johnson’s vaccine are from Pennsylvania.